Author Archive

Law Catalyst

Law Catalyst

legal,intelligencer

Risperdal Accords Don’t Mean Swift End to Litigation by P.J. D’Annunzio, The Legal Intelligencer After settlement of the third case to head to the courtroom in Philadelphia’s Risperdal mass tort, the lead trial attorney
Print

Stephen Sheller was honored with a Lifetime Achievement Award Wednesday, May 20 2015 from American Lawyer Media’s daily newspaper, The Legal Intelligencer. The award was based on his record of verdicts and settlements, service
shire,vyvanse,adderall,whistleblower,stephensheller,qui,tam

American Lawyer Media’s Top Pennsylvania Verdicts and Settlements for 2014 reveals Sheller, P.C. in a familiar spot again in 2014. The firm has been at or near the top of the list for
seroquel whistleblower,astrazeneca

April 27, 2010: In the third record whistleblower settlement for Sheller, P.C. in fifteen months, the firm represented a whistleblower who brought forth knowledge of wrongdoing by AstraZeneca. AstraZeneca agreed to a civil

ON TV: Stephen A. Sheller appeared on “How is Pharma Faring in the Courts?” on The American Law Journal The American Law Journal on CNN News Philadelphia affiliate WFMZ-TV 2015-04-06  
Screenshot 2015-05-08 10.18.14

Stephen Sheller appeared on the Philadelphia CNN-News affiliate WFMZ-TV program The American Law Journal on “How  Is Pharma Faring in the Courts?”  Host Christopher Naughton welcomed plaintiff’s attorneys Christopher Placitella, Esq. of Cohen Placitella & Roth, Stephen Sheller
top,pa,pennsylvania,verdict,settlement,johnson,johnson,j,and,janssen,risperdal,whistleblower,qui,tam,legal,intelligencer,stephensheller

Sheller, P.C. had the largest settlement in Pennsylvania in 2013-2014 as published in American Lawyer Media’s Legal Intelligencer newspaper. The $2.2 billion settlement with Janssen Pharmaceuticals, a division of Johnson & Johnson, was

Bloomberg News reports that Takeda Pharamaceuticals Company, manufacturer of the Type 2 diabetes oral medicine ACTOS®, has recently agreed to pay $2.2 billion dollars to resolve claims of hiding the serious side effects of

Recent studies conducted by the FDA now requires all manufacturers to warn patients of possible risk of heart attack and stroke, and to properly label approved usage 2015-03-03 The Food and Drug Agency (FDA) has
steve,stephen,sheller,humanitarian,award,cchr

Stephen Sheller was honored as “Humanitarian of the Year” by the Citizens Commission on Human Rights (CCHR). The black tie event was held at the Los Angeles Westin Bonaventure February 28, 2015. The